Dr. Eleonora Dronca

Arii de interes: 

  • Genetica medicala: tehnici de genetica moleculara pentru diagnosticul bolilor genetice; consult/consiliere genetica
  • Boli de neurodezvoltare si neurodegenerative
  • Boli congenitale de metabolism
  • Boli mitocondriale
  • Farmacogenetica

Cursuri postuniversitare: 

  • 2013: Dysmorphology Course, ESHG, Manchester, Marea Britanie
  • 2013: Al 7-lea curs Roman-German de Genetica medicala, Oradea 
  • 2012: Chromosomal disorders, UCLA Medical Center, Department of Pathology and laboratory Medicine 
  • 2012: Molecular Pathobiology Short Course, Cluj-Napoca (20.04.2012)
  • 2011: Curs de Citogenetica moleculara, Institutul National de Cercetare-Dezvoltare V. Babes, Bucuresti 
  • 2010: Abordarea interdisciplinara a bolilor genetice rare, UMF Timisoara & Societatea Romana de Genetica medicala 
  • 2006: Impactul geneticii in patologia umana, UMF Cluj-Napoca & Societatea Romana de Genetica medicala 
  • 2005: Al 4-lea curs Germano-Roman de Genetica medicala, UMF Oradea & Societatea Romana de Genetica medicala & Universitatile din Minz, Essen si Wurzburg, Germania & Nijmegen, Olanda & UMF Iasi2004: Biotehnologii moleculare – aplicatii medicale, Catedra de Biochimie, UMF Cluj-Napoca 

Publicatii: 

  • Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics, Clin Psychopharmacol Neurosci 16(1):32-38
  • Low Retinal Dehydrogenase 1 (RALDH1) Level in Prepubertal Boys with Autism Spectrum Disorder: A Possible Link to Dopamine Dysfunction? Clin Psychopharmacol Neurosci 15(3):229-236
  • Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder, Metab Brain Dis 31:887-890 
  • Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus, Acta Biochimica Polonica 63(3):511-515
  • Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents, Revista Romana de Medicina de Laborator 23(4):385-396 
  • Paraoxonase 1 genotype-phenotype correlation in patients with metabolic syndrome, Rom J Morphol Embryol 56(2):387-392
  • High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism, Life Sciences 78(19):2244-2248
  • One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders, Journal of Cellular and Molecular Medicine 13(10):4229-4238 
  •  Paraoxonase 1 activities and polymorphisms in autism spectrum disorders, Journal of Cellular and Molecular Medicine 14(3):600-607
  •  Distribution of Paraoxonase 1 polymorphisms and activities in obese patients, Rev Romana Med Lab 21(4):381-389
  •  Antioxidant enzymes activity in subjects with Parkinson’s disease under L-DOPA therapy, Human and Veterinary Medicine 8(2):124-127 
  •  Cytogenetic and fragile X testing in a group of Romanian autistic children, Human and Veterinary Medicine 7(4):276-282
  •  Statusul PON1 in schizofrenie, Clujul Medical LXXX(2):336-341 ISSN 1222-2119
  •  Paraoxonase (PON1) polymorphisms in autism, Annals of West University of Timisoara Series of Chemistry 16(2):163-168
  •  Correlation between several extrinsic factors and Paraoxonase 1 activities, Human and Veterinary Medicine 5(3):88-93
  •  Investigation of the paraoxonase 1 (PON1) promoter polymorphism C(-108)T and activities in autism spectrum disorders, Rom J Biochem 46(1):13–23
  •  Sindroame genetice in autism, Maramuresul medical XV(53):70-74

Membru in: 

  • Societatea Romana de Genetica Medicala (SRGM)
  • Societatea Europeana de Genetica Medicala (ESHG)
  • Societatea Romana de Neurostiinte (SRN)
  • Societatea Romana de Morfologie (SRM)